Informazione:
Errore:
ID
37914
Descrizione
Study ID: 104864/627 Clinical Study ID: 104864/627 Study Title: An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00061308 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan, Gemcitabine Study Indication: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
Keywords
versioni (1)
- 30/08/19 30/08/19 -
Titolare del copyright
GlaxoSmithKline
Caricato su
30 agosto 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Intravenous Topotecan and Gemcitabine as Second-line Treatment in Patients With Ovarian Cancer NCT00061308
Course 2 (Day 1) - Eligibility; Vital Signs; Administration of Study Medications
Similar models
Course 2 (Day 1) - Eligibility; Vital Signs; Administration of Study Medications
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Center Number
Item
Center Number
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1709561 (UMLS CUI [1])
Patient ID
Item
Patient ID
text
C2348585 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
CL Item
Visit Not Done (1)
Was this course delayed?
Item
Was this course delayed?
boolean
C0750729 (UMLS CUI [1,1])
C0205421 (UMLS CUI [1,2])
C0205421 (UMLS CUI [1,2])
Item
If course was delayed, reason for delay
integer
C0750729 (UMLS CUI [1,1])
C0205421 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0205421 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
CL Item
Hemoglobin < 9.0 g/dL [90g/L] (1)
CL Item
Neutrophils < 1000 cells/mm3 [< 1.0 x 10*9/L] (2)
CL Item
Platelets < 100,000/mm3 [< 100.0 x 10*9/L] (3)
CL Item
Clinically significant non-hematologic drug related toxicity (4)
CL Item
Other, specify (5)
If other reason for course delay, specify
Item
If other reason for course delay, specify
text
C0750729 (UMLS CUI [1,1])
C0205421 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C0205421 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
Is the patient eligible to continue in the study?
Item
Is the patient eligible to continue in the study?
boolean
C1302261 (UMLS CUI [1])
Systolic Blood Pressure
Item
Systolic Blood Pressure
integer
C0871470 (UMLS CUI [1])
Diastolic Blood Pressure
Item
Diastolic Blood Pressure
integer
C0428883 (UMLS CUI [1])
Pulse
Item
Pulse
integer
C0232117 (UMLS CUI [1])
Temperature
Item
Temperature
float
C0005903 (UMLS CUI [1])
CL Item
°C (1)
CL Item
°F (2)
Weight
Item
Weight
integer
C0005910 (UMLS CUI [1])
CL Item
kg (1)
CL Item
Ib (2)
Body Surface Area
Item
Body Surface Area
float
C0005902 (UMLS CUI [1])
Item Group
Administration of Study Medications
C3469597 (UMLS CUI-1)
C0304229 (UMLS CUI-2)
C0304229 (UMLS CUI-2)
Were the study medications administered at Day 1?
Item
Were the study medications administered at Day 1?
boolean
C3469597 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Item
If study medication was not administered at Day 1, mark reason(s) why
integer
C3469597 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C2826287 (UMLS CUI [2])
C0304229 (UMLS CUI [1,2])
C2826287 (UMLS CUI [2])
Code List
If study medication was not administered at Day 1, mark reason(s) why
CL Item
Hematology (1)
CL Item
Non-Hematology (2)
CL Item
Other, specify (3)
If other reason for medication not administered, specify
Item
If other reason for medication not administered, specify
text
C3469597 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C2826287 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0304229 (UMLS CUI [1,2])
C2826287 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
Item Group
Topotecan Administration
C3469597 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C0146224 (UMLS CUI-2)
Was the topotecan dose reduced?
Item
Was the topotecan dose reduced?
boolean
C0146224 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C1707814 (UMLS CUI [1,2])
Item
If topotecan dose was reduced, mark reason(s) dose was reduced
integer
C0146224 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
Code List
If topotecan dose was reduced, mark reason(s) dose was reduced
CL Item
Hematology (1)
CL Item
Non-Hematology, specify (2)
If other reason topotecan dose was reduced, specify
Item
If other reason topotecan dose was reduced, specify
text
C0146224 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
Item
Topotecan Dose Modification
integer
C1707811 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0146224 (UMLS CUI [1,2])
CL Item
No change (2)
CL Item
25% reduction (3)
CL Item
50% reduction (4)
CL Item
Other, specify (5)
CL Item
Re-escalation (1)
If other topotecan dose reduction, specify
Item
If other topotecan dose reduction, specify
integer
C1707814 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0146224 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Topotecan scheduled dose
Item
Topotecan scheduled dose
float
C0146224 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C3174092 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
Total mg to be given (Topotecan)
Item
Total mg to be given (Topotecan)
float
C0178602 (UMLS CUI [1,1])
C0439810 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0439810 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
Date Administered (Topotecan)
Item
Date Administered (Topotecan)
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
Start Time (Topotecan)
Item
Start Time (Topotecan)
time
C1301880 (UMLS CUI [1])
C0146224 (UMLS CUI [2])
C0146224 (UMLS CUI [2])
Stop Time (Topotecan)
Item
Stop Time (Topotecan)
time
C1522314 (UMLS CUI [1])
C0146224 (UMLS CUI [2])
C0146224 (UMLS CUI [2])
Was complete dose given? (Topotecan)
Item
Was complete dose given? (Topotecan)
boolean
C3174092 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0205197 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
If complete dose Topotecan was not given, provide actual mg given:
Item
If complete dose Topotecan was not given, provide actual mg given:
float
C3174092 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0205197 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
Item Group
Gemcitabine Administration
C3469597 (UMLS CUI-1)
C0045093 (UMLS CUI-2)
C0045093 (UMLS CUI-2)
Was the gemcitabine dose reduced?
Item
Was the gemcitabine dose reduced?
boolean
C0045093 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C1707814 (UMLS CUI [1,2])
Item
If gemcitabine dose was reduced, mark reason(s) dose was reduced
integer
C0045093 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
Code List
If gemcitabine dose was reduced, mark reason(s) dose was reduced
CL Item
Hematology (1)
CL Item
Non-Hematology, specify (2)
If other reason gemcitabine dose was reduced, specify
Item
If other reason gemcitabine dose was reduced, specify
text
C0045093 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C1707814 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
Item
Gemcitabine Dose Modification
integer
C1707811 (UMLS CUI [1,1])
C0045093 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,2])
CL Item
No change (2)
CL Item
25% reduction (3)
CL Item
50% reduction (4)
CL Item
Other, specify (5)
CL Item
Re-escalation (1)
If other gemcitabine dose reduction, specify
Item
If other gemcitabine dose reduction, specify
integer
C1707814 (UMLS CUI [1,1])
C0045093 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0045093 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Gemcitabine scheduled dose
Item
Gemcitabine scheduled dose
float
C0045093 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C3174092 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
Total mg to be given (Gemicitabine)
Item
Total mg to be given (Gemicitabine)
float
C0178602 (UMLS CUI [1,1])
C0439810 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
C0439810 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
Date Administered (Gemicitabine)
Item
Date Administered (Gemicitabine)
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
Start Time (Gemicitabine)
Item
Start Time (Gemicitabine)
time
C1301880 (UMLS CUI [1,1])
C0045093 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,2])
Stop Time (Gemicitabine)
Item
Stop Time (Gemicitabine)
time
C1522314 (UMLS CUI [1,1])
C0045093 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,2])
Was complete dose given? (Gemicitabine)
Item
Was complete dose given? (Gemicitabine)
boolean
C3174092 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
If complete dose Gemcitabine was not given, provide actual mg given:
Item
If complete dose Gemcitabine was not given, provide actual mg given:
float
C3174092 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0045093 (UMLS CUI [1,3])